ABOUT ENRICH LAB

Formulation development and OEM production for indie skincare brands

Enrich Enterprises Xiamen Limited, founded in 2007, is a formulation development and OEM production company based in Xiamen, China. We bring formulation, manufacturing, compliance and project execution together to help indie skincare brands turn product ideas into commercially ready products.

Est. [2007]

Founded in Xiamen, China

[US·EU·UK]

Core regulatory markets

[10]+

Brands served

[6]

R&D formulators on staff

OUR EVOLUTION

From Products, To Systems

2007

MANUFACTURING

We started in OEM trading, then moved into manufacturing — packaging, filling, quality control.

Our original office, Xiamen, 2007

2020

LABORATORY

We began developing our own skincare formulas — turning products into experiments, then knowledge.

Early skincare formulation samples, 2020

2024

STANDARDIZATION

Our first partnership showed the same problems on every project — so we built a repeatable process.

Product development workspace, 2024

2026

ENRICHLAB

Today we bring formulation, manufacturing, and process together — not just making, but getting it right.

New office and brand identity, 2026

HOW WE PARTNER

Working principles, stated upfront

Timelines and MOQs are fixed before development starts.

No renegotiation once formulation work begins — quoted terms are the terms.

We decline projects where compliance cannot be completed before production.

If a formula can't clear FDA 21 CFR or EU Regulation 1223/2009 requirements for the target market, we say so before any sampling round — not after.

Formula IP ownership is defined in writing, not assumed.

Every development agreement specifies who owns the final formula before the first prototype is made.

One point of contact through the full development cycle.

No handoffs between departments mid-project — the team that scopes the brief sees it through to bulk production.

See how we've partnered with brands.

View case studies →

Built around the strictest compliance requirements.

Our formulation process is developed against US FDA and EU CPNP requirements — the two most stringent standards in the industry — which is why the US and EU are our primary markets. We also support brands entering other markets where our capabilities align — get in touch to discuss your target region.

OUR TEAM